Stämm Secures $17M Series A Round

PRESS RELEASE — SAN FRANCISCO, March 16, 2022 /PRNewswire/ — Stämm, a biotechnology company developing an innovative biomanufacturing platform of continuous and autonomous production at an industrial scale, today announced closing a Series A, securing $17M. Stämm will use this funding to prepare for commercialization of its technology; to further develop biopharma partnerships into pilot-scale; to enhance its operational …

Stämm Secures $17M Series A Round Read More »